Differential neurotrophic effects of apolipoprotein E in aged transgenic mice

Neuroscience Letters

Volumn 265, Issue 3, 1999, Pages 218-222

  Veinbergs, Isaac ^a   Mallory, Margaret ^a   Mante, Michael ^a   Rockenstein, Edward ^a   Gilbert, John R ^a   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; Gene knock out; Neurodegeneration; Transgenic

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGE; ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; DENDRITE; GENE OVEREXPRESSION; KNOCKOUT GENE; MALE; MAZE TEST; MOUSE; NERVE CELL DEGENERATION; NERVE CELL GROWTH; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TASK PERFORMANCE; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN CHEMISTRY; COGNITION; DENDRITES; FRONTAL LOBE; GAP-43 PROTEIN; HUMANS; MAZE LEARNING; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; NERVE DEGENERATION; SYNAPSES;

EID: 0033597195     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00243-8     Document Type: Article

References (21)

1. Anderson R., Barnes J.C., Bliss T.V.P., Cain D.P., Cambon K., Davies H.A., et al. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mice. Neuroscience. 85:1998;93-110.
2. Anderson R., Higgins G.A. Absence of central cholinergic deficits in apoE knockout mice. Psychopharmacology. 132:1997;135-144.
3. Chen Y., Lomnitski L., Michaelson D.M., Shohami E. Motor and cognitive deficits in apolipoprotein E deficient mice after closed head injury. Neuroscience. 80:1997;1255-1262.
4. Fagan A.M., Murphy B.A., Patel S.N., Kilbridge J.F., Mobley W.C., Bu G., Holtzman D.M. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151:1998;314-325.
5. Fox L., Mallory M., Achim C., Masliah E. Neurodegeneration and somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56:1997;360-368.
6. Laskowitz D.T., Sheng H., Bart R.D., Joyner K.A., Roses A.D., Warner D.S. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17:1997;753-758.
7. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
8. Masliah E., Armasolo F., Veinbergs I., Mallory M., Samuel W. Cerebrolysin reduces cognitive impairment and neuronal damage in apolipoprotein E-deficient mice. Pharmacol. Biochem. Behav. 62:1999;239-245.
9. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the CNS of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
10. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M., Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751:1997;307-314.
11. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
12. Poirier J., Minnich A., Davignon J. Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann. Med. 27:1995;663.
13. Posse de Chaves E.I., Rusinol A.E., Vance D.E., Campenot R.B., Vance J.E. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J. Biol. Chem. 272:(49):1997;30766-30773.
14. Raber J., Wong D., Buttini M., Orth M., Bellosta S., Pitas R.E., Mahley R.W., Mucke L. Differential effects of human apolipoprotein isoforms on spatial learning/memory and exploratory behavior revealed in APOE knockout mice (Abstract). Neurobiol. Aging. 19:1998;S282.
15. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
16. Sheng H., Laskowitz D.T., Bennett E., Schmechel D.E., Bart R.D., Saunders A.M., Pearlstein R.D., Roses A.D., Warner D.S. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J. Cereb. Blood. 18:1998;361-366.
17. Sun Y., Wu S., Bu G., Onifade M.K., Patel S.N., LaDu M.J., Fagan A.M., Holtzman D.M. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18:1998;3261-3272.
18. Wanj X., Gruenstein E. Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide. J. Cell. Physiol. 173:1997;73-83.
19. Xu P.T., Gilbert J.R., Qiu H.L., Rothrock-Christian T., Settles D.L., Roses A.D., Schmechel D.E. Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci. Lett. 246:1998;65-68.
20. Xu P.T., Schmechel D., Rothrock-Christian T., Burkhart D.S., Qiu H.L., Popko B., Sullivan P., Maeda N., Saunders A.M. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 1:1997;1-18.
21. Zhong-Sheng J., Pitas R.E., Mahley R.W. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. J. Biol. Chem. 273:1998;13452-13460.